BIIB Apr 2023 270.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

10.80

-2.30

(-17.56%)

As of 12:47PM EDT. Market open.

Loading interactive chart…

Motley Fool
Should You Buy Biogen Before a Big July Decision?
Over time, Biogen (NASDAQ: BIIB) created a true success story. Competition for Biogen's MS blockbuster Tecfidera, and for other key products, entered the market. Now, though, Biogen may have found that new growth source.
Zacks
Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?
Biogen Inc. (BIIB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Simply Wall St.
Is There An Opportunity With Biogen Inc.'s (NASDAQ:BIIB) 27% Undervaluation?
Key Insights The projected fair value for Biogen is US$362 based on 2 Stage Free Cash Flow to Equity Biogen's US$265...